Receipt of antimalarials among children aged 6-59 months in Nigeria from 2010 to 2021.

ABSTRACT:

Background

Nigeria has the highest malaria burden globally, and anti-malarials have been commonly used to treat malaria without parasitological confirmation. In 2012, Nigeria implemented rapid diagnostic tests (RDTs) to reduce the use of anti-malarials for those without malaria and to increase the use of artemisinin-based combination therapy (ACT) for malaria treatment. This study examined changes in anti-malarial receipt among children aged 6-59 months during a 12-year period of increasing RDT availability.

Methods

A cross-sectional analysis was conducted using the Nigeria Malaria Indicator Survey (NMIS) data from 2010 (before RDT implementation in 2012), 2015, and 2021. The analysis assessed trends in prevalence of malaria by survey RDT result, and fever and anti-malarial/

SUBMITTER: Olisakwe SC 

PROVIDER: S-EPMC11334568 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature